MCL Featured Stories
April 28, 2025 - Inflammatory bowel disease (IBD) is classified as either Crohn’s disease or ulcerative colitis, based on clinical presentation, endoscopic findings, histopathology, and disease distribution.
November 3, 2025 - In this video, Dr. Andrew McKeon describes how the field of autoimmune neurology testing has changed with the explosion of antibody discovery and discusses the importance of a patient-first, phenotype-based approach.
Mayo Clinic Laboratories' specimen pickup and delivery schedules will be altered due to the upcoming Christmas holiday. To ensure specimen stability and prevent delays, follow the guidelines outlined below for domestic clients and international clients.
September 29, 2025 - This session provides an in depth overview of evolving diagnostic approaches in neuroimmunology.
SAAmplify™-αSYN testing offers unprecedented accuracy in diagnosing Parkinson’s and Lewy body dementia.
This webinar will review the 2026 updates to pathology and laboratory CPT codes, including newly added, deleted, and revised codes.
Register now – Jan. 13, 2026 - PACE/FL - Explore ways of calculating and displaying available laboratory capacity that can be used in coordination with practice and outreach growth plans.
In this episode of the “Leveraging the Laboratory” podcast, Jane Hermansen, outreach manager at Mayo Clinic Laboratories, is joined by Wendy Daigle and Ellen Dijkman Dulkes, outreach solutions specialists. Together, they share practical strategies that outreach programs can consider to strengthen their financial performance.
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories and Trish Simner, Ph.D., a clinical microbiologist at Mayo Clinic to discuss recent news about Protecting Access to Medicare Act (PAMA) reform followed by an in-depth conversation about metagenomics.
New ACR lupus guidelines highlight the vital role of lab testing in monitoring disease and guiding treatment decisions.
LiquidHALLMARK combines DNA and RNA for more accurate cancer profiling, helping patients access lifesaving therapies.
After months of misdiagnoses, Tom Heisler found answers at Mayo Clinic, where advanced renal pathology revealed IgG4-related disease and led to his recovery.
Discover five simple steps to start developing the knowledge and skills to drive financial success for your laboratory outreach program.